Place an order request to the broker. The personal manager will contact you to confirm the order.

Order Summary

Asset: Select instrument
Quantity: -
Price per Unit: ? This price is indicative and shown for informational purposes only. The final execution price may change. -
Total Amount: -

Order Expiration

Order remains active until you cancel it or it gets filled

Order expires at the end of the selected day

Order Placed Successfully

Your order has been submitted! Our team will contact you shortly to confirm.

Order Type: -
Asset: -
Quantity: -
Total Amount: -
Manually record a past trade to keep your portfolio up to date. This helps track your P&L accurately.
Total Amount: $0.00

Trade Added Successfully

Trade recorded! Your portfolio data will be recalculated.

Type: -
Asset: -
Quantity: -
Price: -
Total: -

Chat Options

Web Search
Search the internet for recent information
Portfolio Context
Include your portfolio in the conversation
Market Data
Access real-time market information
Watchlist Context
Include your watchlist companies

STELLANTIS (STLAM.MI)

2026-04-10T10:17:59.510399+00:00

Key Updates

Stellantis shares advanced 2.09% to $6.85 since the April 9th report, extending the recovery rally to 8.42% over five days and 14.73% over one month. The recent momentum reflects technical consolidation above the $6.70 support level established in previous sessions. Two new legal developments emerged with additional class action lawsuit announcements from Rosen Law Firm and Pomerantz Law Firm, both targeting the February 6, 2026 disclosure of €22 billion in charges. The June 8, 2026 lead plaintiff deadline is now approaching, though these announcements represent procedural progression rather than fundamental deterioration. The stock remains severely depressed at -27.56% YTD, trading near multi-year lows as the company navigates its strategic reset.

Current Trend

Stellantis exhibits a downward YTD trend with a -27.56% decline, though recent price action suggests potential stabilization. The stock has established a technical base around $6.00-$6.50 following the catastrophic February sell-off that drove shares from $9.54 to $7.28 in a single session. The current price of $6.85 represents a 14.73% recovery over the past month, indicating nascent buying interest at depressed valuation levels. Six-month performance remains deeply negative at -19.93%, reflecting the sustained impact of the €22.2 billion charge announcement and strategic pivot away from aggressive EV expansion. The stock faces immediate resistance at $7.28 (February 6th closing level) and critical support at $6.00 (recent multi-year low). Volume patterns during the recent recovery suggest cautious accumulation rather than conviction-driven buying.

Investment Thesis

The investment thesis centers on Stellantis's ability to execute a fundamental business reset following overextended EV commitments that resulted in €22.2 billion in charges. The company is pivoting toward hybrid offerings, improving product quality, and repairing dealer relationships under CEO Antonio Filosa's turnaround strategy. Chairman John Elkann maintains the company emerged stronger from its "year of reckoning," positioning for recovery in 2026-2027. Strategic flexibility is demonstrated through potential partnerships with Chinese automakers (Xiaomi, Xpeng) for European operations and discussions to manufacture Leapmotor EVs at the idled Brampton facility. The thesis assumes successful execution of operational restructuring, stabilization of market share in core European and North American markets, and gradual restoration of profitability as the €6.5 billion cash restructuring payment is deployed over four years. Valuation at current levels may offer asymmetric upside if management successfully navigates the transition period, though execution risk remains elevated.

Thesis Status

The investment thesis remains under pressure but shows early signs of operational stabilization. The continued legal proceedings represent backward-looking liability issues rather than new fundamental deterioration, with no material updates to the underlying €22.2 billion charge disclosed in February. Management's strategic initiatives are progressing: discussions with Chinese partners for both European operations and Canadian manufacturing demonstrate proactive portfolio optimization. The mandate for European white-collar workers to return to office full-time signals management's commitment to operational discipline and cultural transformation. However, the thesis faces significant headwinds from the 44,000-vehicle UK recall announced April 2nd, adding operational complexity during the turnaround phase. The suspension of 2026 dividend payments and cancellation of the Ram 1500 BEV program confirm the severity of the strategic reset. Near-term thesis validation requires successful product launches, market share stabilization in Q2 2026, and concrete evidence of improved dealer relations and product quality metrics.

Key Drivers

Legal proceedings continue to evolve with Rosen Law Firm filing a securities class action lawsuit alleging false statements regarding earnings growth potential and electrification strategy between February 26, 2025 and February 5, 2026. Pomerantz Law Firm issued reminder notices for the June 8, 2026 lead plaintiff deadline. These legal developments create overhang but do not alter fundamental operations. The 44,000-vehicle UK recall across eight brands for fire risk related to insufficient clearance between gas filter pipe and belt starter generator adds near-term execution complexity. Strategic initiatives include early-stage discussions to manufacture Leapmotor EVs at the idled Brampton facility, potentially resolving the Canadian production commitment dispute. Chairman Elkann's confidence statement emphasizes focus on product quality, hybrid expansion, and dealer relationship repair. The full-time office return mandate for European white-collar workers signals cultural transformation efforts, though facing union opposition.

Technical Analysis

Stellantis has established a technical base between $6.00-$6.85 following the February capitulation that drove shares from $9.54 to $7.28. The current price of $6.85 represents a 14.73% recovery from the March lows, with the stock forming a potential inverse head-and-shoulders pattern on the daily chart. The 5-day gain of 8.42% indicates short-term momentum, though volume remains below average, suggesting accumulation rather than institutional conviction. Immediate resistance stands at $7.28 (February 6th close), with secondary resistance at $8.00 (psychological level). Critical support exists at $6.34 (April 7th low) and $6.00 (multi-year support). The stock trades well below all major moving averages, with the 50-day MA at approximately $8.50 and 200-day MA near $11.00, confirming the established downtrend. RSI has recovered from oversold territory to neutral levels around 45-50, providing room for further upside without overbought conditions. A sustained break above $7.28 with volume expansion would signal technical confirmation of trend reversal, while failure to hold $6.34 would indicate renewed selling pressure.

Bull Case

Bear Case

CapPilot is AI-powered and can make mistakes. Please double-check responses.

CapPilot leverages generative AI to distill market insights and analysis, as well as answer your questions in chat. While we work hard to ensure accuracy, AI-generated content may occasionally contain inaccuracies or outdated information.

We value your feedback — reporting errors helps us continuously improve.